These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 27609503)
21. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Moore TD; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934 [TBL] [Abstract][Full Text] [Related]
22. Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? Sechi LA; Colussi GL; Novello M; Uzzau A; Catena C Horm Metab Res; 2015 Dec; 47(13):1000-6. PubMed ID: 26667803 [TBL] [Abstract][Full Text] [Related]
23. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Lim PO; Jung RT; MacDonald TM Br J Clin Pharmacol; 1999 Nov; 48(5):756-60. PubMed ID: 10594479 [TBL] [Abstract][Full Text] [Related]
24. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911 [TBL] [Abstract][Full Text] [Related]
28. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT]. HOFFMEISTER W Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959 [No Abstract] [Full Text] [Related]